We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MS licensing agreement.
- Abstract
The article reports on the licensing agreement signature of Merck Serono (MS), a division of Germany's Merck KgaA, with Australia's Bionomics. It mentions that the agreement is to further study, formulate and modernize therapeutics and remedies for immune response ailments and multiple sclerosis. In addition, Bionomics receives financial assistance to be used for its significant projects and payments for royalties. According to the author, Bionomics obtains $2 million and other funds for researching directly.
- Subjects
LICENSE agreements; MERCK Serono SA; BIONOMICS Ltd.; FINANCIAL management; THERAPEUTICS; MULTIPLE sclerosis; AUTOIMMUNE diseases; IMMUNE response; ROYALTIES (Copyright)
- Publication
Chemistry & Industry, 2008, Issue 15, p5
- ISSN
0009-3068
- Publication type
Article